- Přirozený průběh Fabryho choroby: měnící se obraz příčin úmrtí v registru FOS - Fabry Outcome Survey2009 | 1. lékařská fakulta
- FOS - Fabry outcome survey - is a useful tool to document Fabry disease and effects of agalsidase alfaPublikace bez příslušnosti k fakultě
- Demographic in FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study2020 | Publikace bez příslušnosti k fakultě
- Data from FOS - the Fabry Outcome Survey. Clinical features of childrenPublikace bez příslušnosti k fakultě
- Anemia is a new complication in Fabry disease: Data from the Fabry Outcome Survey2005 | 1. lékařská fakulta
- The effect of idursulfase on growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS)2013 | 1. lékařská fakulta
- Misdiagnosis of Anderson Fabry disease: data from FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Data from FOS - the Fabry Outcome Survey. Clinical features of children (1)Publikace bez příslušnosti k fakultě
- Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey2007 | 1. lékařská fakulta
- Renal function in patients with Fabry disease: data from FOS - The Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Cardiac involment in Fabry disease patients: European experience from FOS-the Fabry outcome survey.Publikace bez příslušnosti k fakultě
- FOS - the Fabry Outcome Survey - is a useful tool to document Fabry disease and effects of agalsidase alfaPublikace bez příslušnosti k fakultě
- Cardiac involment in Fabry disease patients: European experince from FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey2004 | 1. lékařská fakulta
- Cardiac involvement in Fabry disease patients: European experifrom FOS - the Fabry outcome surveyPublikace bez příslušnosti k fakultě
- Hyperhidrosis: a new and often eárly symptom in Fabry disease. International experience and data from the Fabry Outcome Survey2006 | 1. lékařská fakulta
- Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis2021 | 1. lékařská fakulta
- Positive European experience with agalsidase alfa in Fabry disease: update from FOS - the Fabry Outcome Survey +1Publikace bez příslušnosti k fakultě
- Enzyme replacement therapy (ERT) in females with Fabry disease: an update from FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Fabry disease: beneficial long-term effects of agalsidase alfe confirmed in FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Safety of agalsidase alfa enzyme replacement therapy in a cohort of 1329 patients in FOS - The Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Rheumatological misdiagnosis of Anderson-Fabry disease, a treatable lysosomal storage disorder - Data from the European Fabry Outcome Survey (2)Publikace bez příslušnosti k fakultě
- Rheumatological misdiagnosis of Anderson-Fabry disease, a treatable lysosomal storage disorder - Data from the European Fabry Outcome Survey (1)Publikace bez příslušnosti k fakultě
- Long-term follow-up in FOS - the Fabry Outcome Survey - confrims beneficial effects of agalsidase alfa on renal and other manifestations of Fabry diseasePublikace bez příslušnosti k fakultě
- Prevalence of neuropathic pain and stroke in patients with Fabry disease enrolled in FOS - Fabry Outcome Survey - before and after enzyme replacement therapy with agalsidase alfaPublikace bez příslušnosti k fakultě
- Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS- the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Effect of enzyme replacement therapy with agalsidase alfa on left ventricular mass in patients with Anderson Fabry disease: two-year results from FOS - the Fabry Outcome SurveyPublikace bez příslušnosti k fakultě
- Enzymatická substituční léčba agalsidázou alfa u nemocných s Fabryho chorobou: analýza dat z registru2009 | 1. lékařská fakulta
